- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Emmessar Biotech & Nutrition Ltd's Board approved Q2FY26 financial results for the quarter ended Sep 30, 2025. Investors, await the detailed earnings report.